-
EP4142780
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4142780
| EP4142780 - METHODS OF GENERATING VACCINES AGAINST NOVEL CORONAVIRUS, NAMED SARS-COV-2 COMPRISING VARIABLE EPITOPE LIBRARIES (VELS) AS IMMUNOGENS [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 03.02.2023 Database last updated on 07.06.2024 | |
| Former | The international publication has been made Status updated on 05.11.2021 | Most recent event Tooltip | 05.06.2024 | New entry: Additional fee for renewal fee: despatch of communication + time limit | Applicant(s) | For all designated states VEL PARTNERS HOLDINGS LLC 36 Mill Plain Road Danbury, CT 06811-5181 / US | [2023/19] |
| Former [2023/10] | For all designated states Primex Clinical Laboratories 16742 Stagg Street Suite 120 Van Nuys, CA 91406 / US | Inventor(s) | 01 /
MANUCHARYAN, Karen La Montana, CDMX 14210 / MX | [2023/10] | Representative(s) | Nederlandsch Octrooibureau P.O. Box 29720 2502 LS The Hague / NL | [2023/10] | Application number, filing date | 21797677.8 | 30.04.2021 | [2023/10] | WO2021US30110 | Priority number, date | US202063018814P | 01.05.2020 Original published format: US 202063018814 P | US202063058890P | 30.07.2020 Original published format: US 202063058890 P | [2023/10] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2021222717 | Date: | 04.11.2021 | Language: | EN | [2021/44] | Type: | A2 Application without search report | No.: | EP4142780 | Date: | 08.03.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 04.11.2021 takes the place of the publication of the European patent application. | [2023/10] | Search report(s) | International search report - published on: | US | 25.11.2021 | Classification | IPC: | A61K39/12, A61P31/14, C40B30/06, C12N15/10, C40B40/10 | [2024/26] | CPC: |
A61P31/14 (EP,KR,US);
A61K39/215 (KR,US);
A61K39/12 (EP);
C07K14/005 (KR);
C07K14/165 (EP);
C12N15/1037 (EP,US);
C40B40/10 (EP);
A61K2039/545 (EP,KR,US);
A61K2039/57 (EP,KR);
|
| Former IPC [2023/10] | A61K39/00, A61K39/215, C40B30/06 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/10] | Title | German: | VERFAHREN ZUR ERZEUGUNG VON IMPFSTOFFEN GEGEN NEUES CORONAVIRUS, BENANNT SARS-COV-2 MIT VARIABLEN EPITOPBIBLIOTHEKEN (VES) ALS IMMUNOGENE | [2023/10] | English: | METHODS OF GENERATING VACCINES AGAINST NOVEL CORONAVIRUS, NAMED SARS-COV-2 COMPRISING VARIABLE EPITOPE LIBRARIES (VELS) AS IMMUNOGENS | [2023/10] | French: | PROCÉDÉS DE GÉNÉRATION DE VACCINS CONTRE UN NOUVEAU CORONAVIRUS, DÉSIGNÉ SARS-COV -2 COMPRENANT DES BIBLIOTHÈQUES D'ÉPITOPES VARIABLES (VELS) EN TANT QU'IMMUNOGÈNES | [2023/10] | Entry into regional phase | 30.11.2022 | National basic fee paid | 30.11.2022 | Search fee paid | 30.11.2022 | Designation fee(s) paid | 30.11.2022 | Examination fee paid | Examination procedure | 30.11.2022 | Examination requested [2023/10] | 02.06.2023 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 27.07.2023 | Renewal fee patent year 03 | Penalty fee | Additional fee for renewal fee | 30.04.2023 | 03 M06 Fee paid on 27.07.2023 | 30.04.2024 | 04 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]WO2004096842 (BC CANCER AGENCY [CA], et al) [Y] 1-3, 24-37 * SEQ ID NO: 35; abstract; claim 59; pg 4, In 13-15; pg 36-38; pg 44, In 28 to pg 45, In 29; pg 50; pg 57-58 *; | [Y]US2019374625 (MANUCHARYAN KAREN [MX], et al) [Y] 1-3, 24-37* claims 1, 5-8, 11, 12, 17; para [0006]-[0012]; [0036]-[0040] * |